On International Epilepsy Day, which is commemorated every year on the second Monday in February, national and international health organizations reiterate the importance of strengthening information, access to treatment, and eliminating the stigma associated with this neurological condition. This date seeks to raise awareness in the community about a disease that can affect people of any age and that, with timely diagnosis and proper management, can be controlled in most cases, according to the World Health Organization (WHO).
Epilepsy is a chronic, noncommunicable brain disorder characterized by recurrent seizures that can manifest as convulsions, loss of consciousness, or behavioral changes caused by abnormal electrical activity in the brain. According to the WHO, around 50 million people worldwide live with epilepsy, making it one of the most common neurological disorders. The organization also notes that about 80% of cases occur in low- and middle-income countries, where access to diagnosis and treatment may be limited.
In Colombia, the Ministry of Health and Social Protection points out that epilepsy can be associated with various factors, such as head injuries, nervous system infections, complications during pregnancy or childbirth, strokes, brain tumors, genetic factors, or harmful substance use. However, in a significant number of cases, no specific cause is identified. The ministry also emphasizes that some cases can be prevented by reducing risk factors, adequate prenatal care, infection prevention, and timely access to health services.
Despite the challenges, epilepsy is a treatable condition. The WHO indicates that up to 70% of people with epilepsy could live without seizures if they receive early diagnosis and appropriate treatment. The international organization also notes that up to 25% of cases could be prevented through health promotion and risk prevention measures, such as protection against head injuries, control of chronic diseases, and timely medical care.
Today, the Specialized Health Unit of the Industrial University of Santander, UISALUD, sees an opportunity to promote health education, encourage early consultation, and strengthen support networks that contribute to the social inclusion of people with this disease. The WHO, PAHO, and the Colombian Ministry of Health and Social Protection agree that accurate information and comprehensive support are essential to reducing stigma and improving the quality of life of those living with this condition.
UISALUD reaffirms its commitment to health promotion, prevention, and comprehensive care for its users, and invites the community to learn about and consult the promotion and prevention resources available at the unit, including psychological care and cognitive therapy services, aimed at the well-being and comprehensive support of our patients.
